Acquiring Company
Celltrix
Acquired Company
IBKS No.25 Special Purpose Acquisition
South KoreaSouth KoreaFinancial ServicesDescription
IBKS No.25 has called an extraordinary shareholders meeting to approve its merger with Celltrix, which would make Celltrix the surviving company. Celltrix would issue 2,758,139 common shares to IBKS No.25 shareholders at a merger ratio of 1:0.4612273, with no separate cash consideration. Dissenting shareholders may exercise appraisal rights at a proposed price of KRW 2,046, and the deal may be terminated if approval fails or dissenting shares reach at least 33.33%.
Who to call at Celltrix, and when
When Celltrix changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Celltrix raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Celltrix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Celltrix. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Celltrix makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired IBKS No.25 Special Purpose Acquisition?
IBKS No.25 Special Purpose Acquisition was acquired by Celltrix, based in South Korea. The deal was reported on November 3, 2026. Celltrix is a South Korean operating company that would survive the proposed merger with IBKS No.25. Celltrix is privately held and operates in Financial Services.
When did Celltrix acquire IBKS No.25 Special Purpose Acquisition?
Celltrix's acquisition of IBKS No.25 Special Purpose Acquisition was reported on November 3, 2026. IBKS No.25 has called an extraordinary shareholders meeting to approve its merger with Celltrix, which would make Celltrix the surviving company. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does IBKS No.25 Special Purpose Acquisition do?
IBKS No.25 Special Purpose Acquisition Co. is a special purpose acquisition company listed on the Korea Exchange under code KR:0099X0. It has called an extraordinary shareholders meeting to approve its merger with Celltrix. It is privately held, and is based in South Korea.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.